Jorge Milone

1.6k total citations · 1 hit paper
30 papers, 1.1k citations indexed

About

Jorge Milone is a scholar working on Hematology, Genetics and Rheumatology. According to data from OpenAlex, Jorge Milone has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Hematology, 16 papers in Genetics and 6 papers in Rheumatology. Recurrent topics in Jorge Milone's work include Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (6 papers). Jorge Milone is often cited by papers focused on Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (14 papers) and Acute Myeloid Leukemia Research (6 papers). Jorge Milone collaborates with scholars based in Argentina, United States and Germany. Jorge Milone's co-authors include Andreas Hochhaus, Hagop M. Kantarjian, Neil P. Shah, Dong‐Wook Kim, Jörge E. Cortes, Delphine Réa, Edo Vellenga, Eric Bleickardt, Michele Baccarani and Jianxiang Wang and has published in prestigious journals such as Nucleic Acids Research, Journal of Clinical Oncology and SHILAP Revista de lepidopterología.

In The Last Decade

Jorge Milone

30 papers receiving 1.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION)

2011 441 citations Hagop M. Kantarjian, Neil P. Shah et al. Blood profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jorge Milone Argentina	10	977	833	577	158	98	30	1.1k
Manuel Ayala Mexico	4	1.0k 1.1×	854 1.0×	548 0.9×	172 1.1×	133 1.4×	10	1.2k
Agnès Guerci‐Bresler France	18	1.4k 1.4×	1.1k 1.4×	546 0.9×	237 1.5×	111 1.1×	53	1.5k
P. Le Coutre Germany	5	1.3k 1.4×	1.1k 1.3×	673 1.2×	245 1.6×	158 1.6×	5	1.6k
Jiří Mayer Czechia	11	748 0.8×	679 0.8×	320 0.6×	161 1.0×	77 0.8×	48	1.0k
Н Д Хорошко Russia	8	767 0.8×	651 0.8×	511 0.9×	126 0.8×	77 0.8×	13	883
Jenny Shan United States	13	1.2k 1.2×	923 1.1×	608 1.1×	121 0.8×	149 1.5×	26	1.3k
Anthony K. Mills Australia	14	892 0.9×	727 0.9×	442 0.8×	248 1.6×	89 0.9×	41	1.1k
Marie‐Pierre Noël France	10	712 0.7×	612 0.7×	314 0.5×	163 1.0×	70 0.7×	15	786
Pedro Enrique Dorlhiac‐Llacer Brazil	12	679 0.7×	595 0.7×	412 0.7×	86 0.5×	103 1.1×	40	836
Franz Gruber Norway	11	619 0.6×	463 0.6×	242 0.4×	61 0.4×	99 1.0×	20	743

Countries citing papers authored by Jorge Milone

Since Specialization

Citations

This map shows the geographic impact of Jorge Milone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Milone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Milone more than expected).

Fields of papers citing papers by Jorge Milone

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Milone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Milone. The network helps show where Jorge Milone may publish in the future.

Co-authorship network of co-authors of Jorge Milone

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Milone. A scholar is included among the top collaborators of Jorge Milone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Milone. Jorge Milone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Massa, Federico, et al.. (2017). Evaluación clínica y de respuesta al tratamiento de pacientes con leucemia mieloide aguda. Estudio multicéntrico.. 21(1). 8–14. 1 indexed citations

Rivas, María Marta, et al.. (2015). Allogeneic hematopoietic stem cell transplantation in the elderly. Predicting the risk for non relapse mortality.. PubMed. 75(4). 201–6. 1 indexed citations

Basquiera, Ana Lisa, María Marta Rivas, Jorge Milone, et al.. (2015). Allogeneic hematopoietic stem cell transplantation in adults with myelodysplastic syndrome: Experience of the Argentinean Group of Bone Marrow Transplantation (GATMO). Hematology. 21(3). 162–169. 1 indexed citations

Shah, Neil P., Philippe Rousselot, Charles A. Schiffer, et al.. (2014). Seven-Year (yr) Follow-up of Patients (pts) with Imatinib-Resistant or -Intolerant Chronic-Phase Chronic Myeloid Leukemia (CML-CP) Receiving Dasatinib in Study CA180-034, Final Study Results. Blood. 124(21). 520–520. 6 indexed citations

Rivas, María Marta, Ana Lisa Basquiera, María Rízzí, et al.. (2012). Long-Term Disease-Free Survival in Patients with Relapsed/Refractory Follicular Lymphoma After Autologous Stem Cell Trasplantation. Blood. 120(21). 2031–2031. 1 indexed citations

Pavlovsky, Carolina, Beatriz Moiraghi, Miguel Arturo Pavlovsky, et al.. (2011). Molecular Monitoring of Imatinib in Chronic Myeloid Leukemia Patients in Complete Cytogenetic Remission: Does Achievement of a Stable Major Molecular Response at any Time Point Identify a Privileged Group of Patients? A Multicenter Experience in Argentina and Uruguay. Clinical Lymphoma Myeloma & Leukemia. 11(3). 280–285. 2 indexed citations

Milone, Jorge. (2011). Santiago Pavlovsky. SHILAP Revista de lepidopterología. 33(1). 85–85. 1 indexed citations

Kantarjian, Hagop M., Neil P. Shah, Jörge E. Cortes, et al.. (2011). Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION). Blood. 119(5). 1123–1129. 441 indexed citations breakdown →

Brümmendorf, Tim H., Jörge E. Cortes, Hagop M. Kantarjian, et al.. (2011). Bosutinib (BOS) as third-line therapy for chronic phase (CP) chronic myeloid leukemia (CML) following failure with imatinib (IM) and dasatinib (DAS) or nilotinib (NIL).. Journal of Clinical Oncology. 29(15_suppl). 6535–6535. 5 indexed citations

10.

Milone, Jorge & Alicia Enrico. (2009). Treatment of Philadelphia chromosome-positive acute lymphoblastic leukemia. Leukemia & lymphoma. 50(sup2). 9–15. 7 indexed citations

11.

Milone, Jorge, et al.. (2007). Rapid Infusion of Rituximab (RIR) Is Well Tolerated and Can Safely Be Delivered in Patients with Lymphoproliferative Diseases.. Blood. 110(11). 4503–4503. 5 indexed citations

12.

Hochhaus, Andreas, P Rousselot, P.E. Dorlhiac‐Llacer, et al.. (2006). Dasatinib (SPRYCEL®) 50mg or 70mg BID Versus 100mg or 140mg QD in Patients with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Resistant or Intolerant to Imatinib: Results of the CA180-034 Study.. Blood. 108(11). 166–166. 10 indexed citations

13.

Basquiera, Ana Lisa, et al.. (2006). Clinical Outcomes in Patients with Relapsed/Refractory Acute Leukemia Treated with FLAG-IDA Regimen.. Blood. 108(11). 4561–4561. 2 indexed citations

14.

Koziner, Benjamín, et al.. (2002). Autologous stem cell transplantation for patients with chronic myeloid leukemia. Cancer. 95(11). 2339–2345. 6 indexed citations

15.

Milone, Jorge. (2002). Identification of mRNA decapping activities and an ARE-regulated 3' to 5' exonuclease activity in trypanosome extracts. Nucleic Acids Research. 30(18). 4040–4050. 34 indexed citations

16.

Milone, Giuseppe, Adam Robinson, Juan Garcia, et al.. (2001). Cell processing practices in Argentina: report of a multicenter survey. Cytotherapy. 3(2). 127–133. 1 indexed citations

17.

Milone, Jorge, et al.. (2001). [Umbilical cord hematopoietic progenitor cells bank].. PubMed. 61(6). 843–8. 2 indexed citations

18.

Milone, Jorge, et al.. (2000). The First Report of Familial Adult T-cell Leukemia/Lymphoma in Argentina. Leukemia & lymphoma. 37(1-2). 225–227. 8 indexed citations

19.

Marín, Gustavo H., et al.. (1999). Graft versus host disease in autologous stem cell transplantation.. PubMed. 18(2). 201–8. 8 indexed citations

20.

Milone, Jorge, et al.. (1998). Complete response in severe thrombotic microangiopathy post bone marrow transplantation (BMT-TM) after multiple plasmaphereses. Bone Marrow Transplantation. 22(10). 1019–1021. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact